Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?
about
Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptorViruses associated with human cancerHIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cellsMolecular virology of Kaposi's sarcoma-associated herpesvirusKaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicitySusceptibility of human fetal mesenchymal stem cells to Kaposi sarcoma-associated herpesvirus.Sulfotyrosines of the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promote tumorigenesis through autocrine activationKSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesisAmplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcomaParacrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesisThe human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cellsFunctional characterization of Kaposi's sarcoma-associated herpesvirus open reading frame K8 by bacterial artificial chromosome-based mutagenesis.The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses.Activation of p90 ribosomal S6 kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus is critical for optimal production of infectious viruses.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivoPotent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirusInhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acidKaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramerRaf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors.Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.Multiple Lytic Origins of Replication Are Required for Optimal Gammaherpesvirus Fitness In Vitro and In VivoKaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein.Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma.A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factorsKaposi's sarcoma and its associated herpesvirus.IKK epsilon kinase is crucial for viral G protein-coupled receptor tumorigenesisThe Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene.Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II.Virion proteins of Kaposi's sarcoma-associated herpesvirus.Viral infection and pulmonary hypertension: is there an association?Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview.Tegument Proteins of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses.Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis.Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis.
P2860
Q24564062-5C321D45-E2F6-4438-A9F2-A51669E01526Q24653900-15BA9440-BD82-402C-8C5F-9435DE2DEBE5Q28216723-2BCE8227-CD2F-437C-A08F-041CC2A2A4E9Q28363323-AD11C22E-ED40-4F78-A2B6-4CD3D061A942Q28473623-A0184993-B255-4358-8AAC-A581A5D97F10Q30433906-01C934AE-2C70-4204-AE78-8188212FAC04Q33725623-5C8FB3A7-3164-4B72-B8D5-2C6CBEA87FC2Q33761091-135FA123-5380-40BD-8DC1-8968C1DE9C80Q33854532-E942A8D4-FA40-43EC-B779-DEC41549B92BQ33895137-1474E82E-16BF-48EC-94B8-51E5BB091968Q34068117-9B61F554-B468-463E-9F61-05E5C7CF82D8Q34512207-E66BAEFB-742A-49CB-879A-D8902788C37AQ34741784-861E88E7-8C28-4A2B-BD09-22E450F21C7BQ34929196-1C73DE22-DA2B-42F6-AFC2-6A22180479A4Q34992555-FC02645F-222B-47B9-9E71-926B747FA6EAQ35026060-660CAB6D-C094-44D3-AF26-983728203B3DQ35158385-E2B48F0C-2300-4EF4-BF02-E02681E60631Q35546590-73443933-8041-42AC-87CC-6E06865787F0Q35689364-92CE248F-F34A-4F7D-ADC8-8A5434579B6FQ35702343-496E7FBF-39A5-401E-BF8E-3CA05FC8A740Q35857736-0E007F8F-7F0E-4C5F-927C-73275DC79CF3Q35911472-82E0AF58-D301-4874-A6D3-C19A4DB7DD7CQ35917368-86A47736-181A-44F2-8E33-880847CC0490Q35967300-AD0827AE-672A-4D0C-8673-7FB693B4FD19Q36019173-E38452B3-2B8E-45EE-84ED-2661159B93AEQ36301349-5ABA6031-FBF1-4DFE-A90F-2DF3DD70D3EFQ36315189-988FAC7A-E4B9-4185-9721-472BBA585A77Q36340825-6F2F4CDA-7D89-4FD5-92FA-094717B4E9EDQ36415707-829FBAD5-9326-4672-BE97-82BB13BA8338Q36484112-610AE0EA-AD0C-49C0-960B-315157650208Q36487309-C54A4BB1-E562-43F3-9626-CA82B64E6513Q36990765-888E2118-5BD3-4184-9C25-86272CF18ABDQ37070142-610A6A7F-2E5B-4C3D-8964-1CE3C5E90672Q37544369-FD2DC12D-4452-47BA-B4EC-B2746640467CQ37744006-B0E61BBB-69F1-48BC-B2FE-B9EC3F9A31DDQ37867671-5C3C2931-1E4E-44E3-B681-7AB66AE4354FQ37903168-B45EC426-CE38-490A-9A9F-2ABFC147CD35Q37995595-9CB443C5-259E-40A2-B51B-D1B48A0AE3E8Q38160783-0EE8DCAC-8392-474A-BC8C-730618C1DC2BQ38338235-AC45BDAC-F52D-4F9A-885F-13CA58BC1215
P2860
Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?
@en
type
label
Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?
@en
prefLabel
Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?
@en
P2093
P2860
P356
P1476
Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?
@en
P2093
E Cesarman
M C Gershengorn
P2860
P304
P356
10.1084/JEM.191.3.417
P407
P577
2000-02-01T00:00:00Z